511
Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)
Condition(s):Non-Small Cell Lung Cancer (NSCLC)Last Updated:May 5, 2014Completed
Vinorelbine: 521 Clinical Trials, Page 52 of 53
Hide Studies Not Open or Pending
512
A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)
Condition(s):Non-Small Cell Lung Cancer; Brain NeoplasmsLast Updated:January 6, 2023Completed
513
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
Condition(s):Breast CancerLast Updated:February 22, 2018Terminated
514
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Condition(s):Carcinoma, Non-Small-Cell Lung; Immune-Related Adverse EventsLast Updated:May 28, 2020Unknown status
515
Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma
Condition(s):Carcinoma, Non-Small-Cell Lung; Synchronous NeoplasmsLast Updated:March 3, 2017Unknown status
516
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Condition(s):Breast Neoplasm; Breast Cancer; Hormone Receptor Positive Tumor; HER2-negative Breast Cancer; Advanced Breast CancerLast Updated:January 4, 2023Recruiting
517
Study of Neoadjuvant Chemotherapy of Breast Cancer
Condition(s):Breast CancerLast Updated:July 13, 2012Unknown status
518
Imaging Perfusion Restrictions From Extracellular Solid Stress – An Open-label Losartan Study
Condition(s):Glioblastoma; Brain MetastasesLast Updated:April 25, 2022Recruiting
519
CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy
Condition(s):Nasopharyngeal CarcinomaLast Updated:May 18, 2018Not yet recruiting
520
B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes
Condition(s):Classical Hodgkin Lymphoma; Relapsed or Refractory Classical Hodgkin LymphomaLast Updated:June 25, 2021Completed